← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 8, 2020Last known activity
Jun 30, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 2 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT04447326CollaboratorPhase 2Jun 30, 2020
- NCT04309240Reponsible party - principal investigatorPhase 3Mar 8, 2020
- NCT04309240Study chairPhase 3Mar 8, 2020
- NCT04309240Lead sponsorPhase 3Mar 8, 2020
Details
- Last known activity
- Jun 30, 2020